Trends, Patterns, and Public Health Implications of the last 10 years Dietary Supplement Recalls of the Greek National Organization for Medicines are extracted and analyzed.
A 92-year-old woman with normal systolic function had recently begun using the newly approved phosphodiesterase III inhibitor cilostazol when she was admitted with lower-extremity pain. Cilostazol is
